ESC 365 - Baseline stroke and bleeding risks in the global edoxaban treatment in routine clinical practice in patients with non-valvular atrial fibrillation programme (global ETNA-AF): first snapshot analysis

ESC Premium Access

Baseline stroke and bleeding risks in the global edoxaban treatment in routine clinical practice in patients with non-valvular atrial fibrillation programme (global ETNA-AF): first snapshot analysis

Session: Poster Session 3 - Atrial fibrillation - Epidemiology prognosis outcome

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor P. Kirchhof (Hamburg, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

61 presentations

8 followers

9 more presentations in this session

Clinical significance of postoperative atrial arrhythmias in patients who underwent lung transplantation

Speaker: Doctor B. Kim (Seoul, KR)

The CHA2DS2VASc score as a predictor of cardiovascular events in patients without atrial fibrillation

Speaker: Assistant Professor F. Ricci (Chieti, IT)

Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry

Speaker: Professor S. Dubner (Buenos Aires, AR)

Paroxysmal atrial fibrillation is very common in a geriatric population evaluated for syncope

Speaker: Doctor R. Jansen (Alkmaar, NL)

The economic burden attributable to atrial fibrillation in nine European countries: perspectives from the GARFIELD-AF registry

Speaker: Mr P. Cozzolino (Monza, IT)

Access the full session

Poster Session 3 - Atrial fibrillation - Epidemiology prognosis outcome

Speakers: Professor P. Kirchhof, Doctor B. Kim, Assistant Professor F. Ricci, Professor S. Dubner, Doctor R. Jansen...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources